- Home
- Insider Trading Stock Activity
- Hopkinson Craig C.
Stock Insider Trading Activity of Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Avg Cost/Share
$30.00
Shares
5,000
Total Value
$150,005.00
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$29.30
Shares
4,000
Total Value
$117,200.00
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$30.38
Shares
9,000
Total Value
$273,441.60
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$31.53
Shares
9,000
Total Value
$283,776.30
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$34.00
Shares
349,340
Total Value
$11,848,975.19
Owned After
61,740
EVP R&D, Chief Medical Officer
Avg Cost/Share
$32.05
Shares
100,918
Total Value
$3,234,381.53
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$32.07
Shares
61,151
Total Value
$1,961,406.09
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$31.50
Shares
9,221
Total Value
$290,461.50
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$30.77
Shares
14,349
Total Value
$441,550.30
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$30.08
Shares
58,996
Total Value
$1,774,576.08
Owned After
61,740
SEC Form 4
EVP R&D, Chief Medical Officer
Avg Cost/Share
$29.53
Shares
10,471
Total Value
$309,168.84
Owned After
61,740
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Jan 8, 2026 | Sell | $30.00 | 5,000 | $150,005.00 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Dec 1, 2025 | Sell | $29.30 | 4,000 | $117,200.00 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Nov 3, 2025 | Sell | $30.38 | 9,000 | $273,441.60 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Oct 15, 2025 | Sell | $31.53 | 9,000 | $283,776.30 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Feb 12, 2025 | Sell | $34.00 | 349,340 | $11,848,975.19 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Jan 30, 2025 | Sell | $32.05 | 100,918 | $3,234,381.53 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Dec 9, 2024 | Sell | $32.07 | 61,151 | $1,961,406.09 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Dec 5, 2024 | Sell | $31.50 | 9,221 | $290,461.50 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Dec 4, 2024 | Sell | $30.77 | 14,349 | $441,550.30 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Nov 11, 2024 | Sell | $30.08 | 58,996 | $1,774,576.08 | 61,740 | |
| Hopkinson Craig C. | ALKS | EVP R&D, Chief Medical Officer | Nov 6, 2024 | Sell | $29.53 | 10,471 | $309,168.84 | 61,740 |